Skip to content
[P]pubcas
Independent chemical reference Compare
Chemical substance record

Nalidixic acid

389-08-2C12H12N2O3232.239 g/mol

A monocarboxylic acid comprising 1,8-naphthyridin-4-one substituted by carboxylic acid, ethyl and methyl groups at positions 3, 1, and 7, respectively. An orally administered antibacterial, it is used in the treatment of lower urinary-tract infections due to Gram-negative bacteria, including the majority of E. coli, Enterobacter, Klebsiella, and Proteus species. — ChEBI

Safety references

Safety documents & references

Supplier matching matters

Find the safety document for your specific supplier, product number and grade.

Find a product-specific SDS

Safety guides and government classification records are not a manufacturer’s SDS. Match supplier, product number, concentration, physical form, region and revision before using a document.

Identity & molecular properties

Source-linked values
CAS number389-08-2ChEBI ↗
Molecular formulaC12H12N2O3ChEBI ↗
Molar mass232.239 g/molChEBI ↗
Monoisotopic mass232.08479 DaChEBI ↗
Formal charge0ChEBI ↗
ChEBI identifierCHEBI:100147ChEBI ↗

Cross-source molecular data

PubChem
Molar mass232.23 g/molPubChem ↗
Exact mass232.08479225 DaPubChem ↗
Computed XLogP1.4PubChem ↗
Topological polar surface area (Ų)70.5PubChem ↗
H-bond donors1PubChem ↗
H-bond acceptors5PubChem ↗
Rotatable bonds2PubChem ↗

PubChem computed values are shown separately from the ChEBI record. An exact InChIKey match was used to connect the records. Molecular descriptors do not describe a supplied product’s purity, particle size or performance.

Names & structural identifiers

Copy any identifier
nalidixic acid
1-ethyl-7-methyl-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid
MHWLWQUZZRMNGJ-UHFFFAOYSA-N
CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21
InChI=1S/C12H12N2O3/c1-3-14-6-9(12(16)17)10(15)8-5-4-7(2)13-11(8)14/h4-6H,3H2,1-2H3,(H,16,17)

Names & synonyms

1-ethyl-7-methyl-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acidacide nalidixiqueacido nalidixicoacidum nalidixicum

Names are supplied by ChEBI. Trade names and related synonyms may describe a broader product context.

Classification & relationships

ChEBI ontology

Roles recorded in ChEBI

antimicrobial agentantibacterial agentantibacterial drugDNA synthesis inhibitor

Database role annotations describe reported biological or chemical roles; they are not product approvals or recommendations for use.

Mass ↔ amount of substance

Calculated from sourced mass
Equivalent amount
0.00430591 mol

Uses 232.239 g/mol from ChEBI. Assumes the substance described by this record; no purity or concentration correction is applied.

Elemental composition

Theoretical mass fractions
C
Carbon · 12 atoms
62.06%
O
Oxygen · 3 atoms
20.67%
N
Nitrogen · 2 atoms
12.06%
H
Hydrogen · 12 atoms
5.21%

Calculated theoretical mass fractions from the reported formula and PubChem periodic-table atomic masses. These are not assay or purity results.

Research & patent references

Selected source associations
Nalidixic acid is still the drug of choice for shigellosis in Pakistan. ↗JPMA. The Journal of the Pakistan Medical Association · 2001 Feb · PMID 11321869
BE612258 · Patent reference ↗Patent cross-reference supplied by ChEBI. Association alone does not establish claim scope.
US3590036 · Patent reference ↗Patent cross-reference supplied by ChEBI. Association alone does not establish claim scope.

Sources & record history

Checked 27 Sep 2026
EMBL-EBI ChEBI · CHEBI:100147

Release 255, 9 September 2026. ChEBI three-star (manually annotated) source entry. View original record ↗ · CC BY 4.0

NCBI PubChem · CID 4421 · retrieved 2026-09-27

PubCAS formats source data, connects references and computes explicitly labelled conversions. CAS cross-references are supplied by ChEBI; they do not constitute CAS verification or endorsement.